Vossloh reports strong Q2 with 19% EBIT beat and double-digit sales growth

Vossloh AG reported strong Q2 2025 results, with sales up 13% to €332 million and EBIT increasing 19% to €37.5 million, both exceeding analyst expectations, primarily driven by its Customized Modules and Core Components segments. However, the company faced headwinds with a 32% year-over-year decline in order intake, a book-to-bill ratio of 0.9x, and negative free cash flow of -€6.9 million. Despite these mixed signals, management reaffirmed full-year guidance, anticipating 9% sales growth in H2 2025 and expecting demand from China to materialize towards year-end.

Analysis

Vossloh AG (VOSG) reported a strong second quarter, with sales increasing 13% year-over-year to €332 million and EBIT growing 19% to €37.5 million, surpassing consensus estimates by 4% and 19% respectively. This performance was driven by robust growth in the Customized Modules (+20%) and Core Components (+14%) segments, leading to an improved EBIT margin of 11.3%. However, these positive results are contrasted by weakening forward-looking indicators. Order intake fell by a significant 32% year-over-year, causing the book-to-bill ratio to drop to 0.9x from 1.4x in the prior quarter, signaling that sales are outpacing new orders. Consequently, the order backlog has decreased by 4% year-over-year. Most concerning is the sharp deterioration in cash flow, with operating cash flow collapsing to €3.5 million from €26.0 million and free cash flow turning negative to -€6.9 million. Despite these headwinds, management reaffirmed its full-year guidance, which hinges on an anticipated 9% sales growth in the second half of 2025 and demand from China materializing toward year-end.

Key Decisions for Investors

• Investors should weigh the company's strong current profitability and earnings beat against the significant deterioration in forward-looking metrics, particularly the 32% decline in order intake and negative free cash flow.
• The sub-1.0x book-to-bill ratio is a key metric to monitor, as a continuation of this trend could signal future revenue deceleration despite the reaffirmed guidance.
• Management's full-year forecast appears heavily dependent on a year-end recovery in Chinese demand and the successful post-summer integration of the Sateba acquisition, representing the primary catalysts and risks for the stock.
• The sharp reversal in free cash flow from a positive €24.9 million to a negative €6.9 million warrants close scrutiny of the company's working capital management and capital expenditure.